Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2020

Open Access 01-12-2020 | Diabetic Foot | Research article

Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study

Authors: B. Zantour, S. Bouchareb, Z. El Ati, F. Boubaker, W. Alaya, W. Kossomtini, M. H. Sfar

Published in: BMC Endocrine Disorders | Issue 1/2020

Login to get access

Abstract

Background

Diabetic foot is an underestimated and redoubtable diabetes complication. The aims of our study were to assess diabetic foot ulcer risk factors according to International Working Group on the Diabetic Foot (IWGDF) classification, stratify patients into risk categories and identify factors associated with higher-risk grade.

Methods

Cross-sectional setting over a period of 07 months, patients were randomly selected from the diabetic outpatients attending our unit of diabetology. Questionnaire and clinical examination were made by the same physician. Patients free of active foot ulcer were included.

Results

Among 230 patients evaluated, 10 had an active foot ulcer and were excluded. Five patients (2.27%) had a history of foot ulcer and 3(1.36%) had a lower-limb amputation. Sensory neuropathy, as measured by the 5.07(10 g) Semmes-Weinstein monofilament testing, was present in 23.63% of patients, whereas 36.82% had a peripheral arterial disease based on clinical findings, and 43.63% had foot deformities. According to the IWGDF classification, Group 0: 72.72%, Group 1: 5.9%, Group 2: 17.73% and Group 3: 3.63%. After univariate analysis, patients in higher–risk groups were significantly more often female, had higher age and BMI, longer diabetes duration, elevated waist circumference, low school level, retinopathy and hyperkeratosis. Multivariate logistic regression analysis identified 3 significant independent factors associated with high-risk groups: retinopathy (OR = 2.529, CI95 [1.131–5.655], p = 0.024), hyperkeratosis (OR = 2.658, CI95 [1.222–5.783], p = 0.014) and school level (OR = 0.489, CI95 [0.253–9.44], p = 0.033).

Conclusions

Risk factors for foot ulceration were rather common in outpatients with diabetes. The screening of patients at risk for foot ulceration should start early, integrated with sustainable patient education.
Literature
1.
go back to reference Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Prevention foot care in people with diabetes. Diabetes Care. 1998;21:2161–238.CrossRef Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Prevention foot care in people with diabetes. Diabetes Care. 1998;21:2161–238.CrossRef
2.
go back to reference Dinh TL, Veves A. A review of the mechanisms implicated in the pathogenesis of the diabetic foot. Int J Low Extrem Wounds. 2005;4:154–9.CrossRef Dinh TL, Veves A. A review of the mechanisms implicated in the pathogenesis of the diabetic foot. Int J Low Extrem Wounds. 2005;4:154–9.CrossRef
3.
go back to reference Apelqvist J, Bakker K, Van Houtum WH, Nabuurs-Franssen MH, Schaper NC, The International Working Group on the Diabetic Foot. International consensus on the diabetic foot. Maastricht: Schaper NC Eds; 1999. Apelqvist J, Bakker K, Van Houtum WH, Nabuurs-Franssen MH, Schaper NC, The International Working Group on the Diabetic Foot. International consensus on the diabetic foot. Maastricht: Schaper NC Eds; 1999.
4.
go back to reference Mayfield JA, Reiber GE, Nelson RG, Greene T. A foot risk classification system to predict diabetic amputation in Pima Indians. Diabetes Care. 1996;19:704–9.CrossRef Mayfield JA, Reiber GE, Nelson RG, Greene T. A foot risk classification system to predict diabetic amputation in Pima Indians. Diabetes Care. 1996;19:704–9.CrossRef
5.
go back to reference Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31:1679–85.CrossRef Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31:1679–85.CrossRef
6.
go back to reference Peters EJG, Lavery LA. Effectiveness of the diabetic foot risk classification system of the international working group on the diabetic foot. Diabetes Care. 2001;24:1442–7.CrossRef Peters EJG, Lavery LA. Effectiveness of the diabetic foot risk classification system of the international working group on the diabetic foot. Diabetes Care. 2001;24:1442–7.CrossRef
7.
go back to reference Leymarie F, Richard JL, Malgrange D, on the behalf of the French working group on the diabetic foot. Factors associated with diabetic patients at high risk for foot ulceration. Diabetes Metab. 2005;31:603–5.CrossRef Leymarie F, Richard JL, Malgrange D, on the behalf of the French working group on the diabetic foot. Factors associated with diabetic patients at high risk for foot ulceration. Diabetes Metab. 2005;31:603–5.CrossRef
8.
go back to reference Mugambi-Nturibi E, Otieno CF, Kwasa TO, Oyoo GO, Acharya K. Stratification of persons with diabetes into risk categories for foot ulceration. East Afr Med J. 2009;86:233–9.PubMed Mugambi-Nturibi E, Otieno CF, Kwasa TO, Oyoo GO, Acharya K. Stratification of persons with diabetes into risk categories for foot ulceration. East Afr Med J. 2009;86:233–9.PubMed
9.
go back to reference Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2000;16(Suppl 1):84–92.CrossRef Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2000;16(Suppl 1):84–92.CrossRef
10.
go back to reference Williams DT, Price P, Harding KG. The influence of diabetes and lower limb arterial disease on cutaneous foot perfusion. J Vasc Surg. 2006;44:770–5.CrossRef Williams DT, Price P, Harding KG. The influence of diabetes and lower limb arterial disease on cutaneous foot perfusion. J Vasc Surg. 2006;44:770–5.CrossRef
11.
go back to reference American Diabetes Association. Standards of medical care of diabetes in 2019. Diabetes Care. 2019;42(Suppl 1):133–8. American Diabetes Association. Standards of medical care of diabetes in 2019. Diabetes Care. 2019;42(Suppl 1):133–8.
12.
go back to reference Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care. 1992;15:1386–9.CrossRef Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care. 1992;15:1386–9.CrossRef
13.
go back to reference Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle diabetic foot study. Diabetes Care. 1999;22:1036–42.CrossRef Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle diabetic foot study. Diabetes Care. 1999;22:1036–42.CrossRef
14.
go back to reference Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:136–54.CrossRef Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:136–54.CrossRef
15.
go back to reference Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract. 2000;49(Suppl 11):17–29. Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract. 2000;49(Suppl 11):17–29.
16.
go back to reference Malgrange D, Richard JL, Leymarie F. Screening diabetic patients at risk for foot ulceration. Diabetes Metab. 2003;29:261–8.CrossRef Malgrange D, Richard JL, Leymarie F. Screening diabetic patients at risk for foot ulceration. Diabetes Metab. 2003;29:261–8.CrossRef
17.
go back to reference Assaad-Khalil SH, Zaki A, Abdel Rehim A, Megallaa MH, Gaber N, Gamal H, et al. Prevalence of diabetic foot disorders and related risk factors among Egyptian subjects with diabetes. Prim Care Diabetes. 2015;9:297–303.CrossRef Assaad-Khalil SH, Zaki A, Abdel Rehim A, Megallaa MH, Gaber N, Gamal H, et al. Prevalence of diabetic foot disorders and related risk factors among Egyptian subjects with diabetes. Prim Care Diabetes. 2015;9:297–303.CrossRef
18.
go back to reference Shahbazian H, Yazdanpanah L, Latifi SM. Risk assessment of patients with diabetes for foot ulcers according to risk classification consensus of international working group on diabetic foot (IWGDF). Pak J Med Sci. 2013;29:730–4.PubMedPubMedCentral Shahbazian H, Yazdanpanah L, Latifi SM. Risk assessment of patients with diabetes for foot ulcers according to risk classification consensus of international working group on diabetic foot (IWGDF). Pak J Med Sci. 2013;29:730–4.PubMedPubMedCentral
19.
go back to reference Murray HJ, Young MJ, Hollis S, Boulton AJ. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med. 1996;13:979–82.CrossRef Murray HJ, Young MJ, Hollis S, Boulton AJ. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med. 1996;13:979–82.CrossRef
20.
go back to reference Vibha SP, Kulkarni MM, Kirthinath Ballala AB, Kamath A, Maiya GA. Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus. BMC Endocr Disord. 2018;18:43.CrossRef Vibha SP, Kulkarni MM, Kirthinath Ballala AB, Kamath A, Maiya GA. Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus. BMC Endocr Disord. 2018;18:43.CrossRef
21.
go back to reference Lavery LA, Peters EJ, Williams JR, Murdoch DP, Hudson A, Lavery DC, International Working Group on the Diabetic Foot. Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care. 2008;31:154–6.CrossRef Lavery LA, Peters EJ, Williams JR, Murdoch DP, Hudson A, Lavery DC, International Working Group on the Diabetic Foot. Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care. 2008;31:154–6.CrossRef
22.
go back to reference Boulton AJ, Armstrong DG, Albert SF. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diab Care. 2008;31:1679–85.CrossRef Boulton AJ, Armstrong DG, Albert SF. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diab Care. 2008;31:1679–85.CrossRef
23.
go back to reference Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA, et al. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3266.PubMed Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA, et al. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3266.PubMed
24.
go back to reference Wu L, Hou Q, Zhou Q, Peng F. Prevalence of risk factors for diabetic foot complications in a Chinese tertiary hospital. Int J Clin Exp Med. 2015;8:3785–92.PubMedPubMedCentral Wu L, Hou Q, Zhou Q, Peng F. Prevalence of risk factors for diabetic foot complications in a Chinese tertiary hospital. Int J Clin Exp Med. 2015;8:3785–92.PubMedPubMedCentral
25.
go back to reference Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig. 2014;5:714–21.CrossRef Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig. 2014;5:714–21.CrossRef
26.
go back to reference Al-Kaabi JM, Al Maskari F, Zoubeidi T, Abdulle A, Shah SM. Prevalence and determinants of peripheral neuropathy in patients with type 2 diabetes attending a tertiary care center in the United Arab Emirates. J Diabetes Metab Disord. 2014;5:2–9. Al-Kaabi JM, Al Maskari F, Zoubeidi T, Abdulle A, Shah SM. Prevalence and determinants of peripheral neuropathy in patients with type 2 diabetes attending a tertiary care center in the United Arab Emirates. J Diabetes Metab Disord. 2014;5:2–9.
27.
go back to reference Khan MIH, Azhar U, Zubair F, Khan ZA. Can we link foot ulcer with risk factors in diabetics? A study in a tertiary care hospital. Pak J Med Sci. 2018;34:1375–80.PubMedPubMedCentral Khan MIH, Azhar U, Zubair F, Khan ZA. Can we link foot ulcer with risk factors in diabetics? A study in a tertiary care hospital. Pak J Med Sci. 2018;34:1375–80.PubMedPubMedCentral
28.
go back to reference Nehring P, Mrozikiewicz-Rakowska B, Krzyżewska M, Sobczyk-Kopcioł A, Płoski R, Broda G. Karnafel W. J Diab Metab Dis. 2014;13:79.CrossRef Nehring P, Mrozikiewicz-Rakowska B, Krzyżewska M, Sobczyk-Kopcioł A, Płoski R, Broda G. Karnafel W. J Diab Metab Dis. 2014;13:79.CrossRef
29.
go back to reference Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998;158:157–62.CrossRef Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998;158:157–62.CrossRef
30.
go back to reference Sohn MW, Budiman-Mak E, Lee TA, Oh E, Stuck RM. Significant J-shaped association between body mass index (BMI) and diabetic foot ulcers. Diabetes Metab Res Rev. 2011;27:402–9.CrossRef Sohn MW, Budiman-Mak E, Lee TA, Oh E, Stuck RM. Significant J-shaped association between body mass index (BMI) and diabetic foot ulcers. Diabetes Metab Res Rev. 2011;27:402–9.CrossRef
31.
go back to reference Gray N, Picone G, Sloan F, Yashkin A. The relationship between BMI and onset of diabetes mellitus and its complications. South Med J. 2015;108:29–36.CrossRef Gray N, Picone G, Sloan F, Yashkin A. The relationship between BMI and onset of diabetes mellitus and its complications. South Med J. 2015;108:29–36.CrossRef
32.
go back to reference Al Mahroos F, Al RK. Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrein. A nation wide primary care diabetes clinic based study. Ann Saudi Med. 2007;27:25–31. Al Mahroos F, Al RK. Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrein. A nation wide primary care diabetes clinic based study. Ann Saudi Med. 2007;27:25–31.
33.
go back to reference Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49:106–16.CrossRef Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49:106–16.CrossRef
34.
go back to reference Sellman A, Katzman P, Andreasson S, Löndahl M. Presence of chronic diabetic foot ulcers is associated with more frequent and more advanced retinopathy. Diabet Med. 2018;35(10):1364–70.CrossRef Sellman A, Katzman P, Andreasson S, Löndahl M. Presence of chronic diabetic foot ulcers is associated with more frequent and more advanced retinopathy. Diabet Med. 2018;35(10):1364–70.CrossRef
35.
go back to reference Mohora M, Virgolici B, Coman A, Muscurel C, Gaman L, Gruia V. Diabetic foot patients with and without retinopathy and plasma oxidative stress. Rom J Intern Med. 2007;45:51–7.PubMed Mohora M, Virgolici B, Coman A, Muscurel C, Gaman L, Gruia V. Diabetic foot patients with and without retinopathy and plasma oxidative stress. Rom J Intern Med. 2007;45:51–7.PubMed
36.
go back to reference Kim CH, Park JY, Kim JY, Choi CS, Kim Y, Chung YE, et al. Elevated serum ceruloplasmin levels in subjects with metabolic syndrome: a population-based study. Metabolism. 2002;51:838–42.CrossRef Kim CH, Park JY, Kim JY, Choi CS, Kim Y, Chung YE, et al. Elevated serum ceruloplasmin levels in subjects with metabolic syndrome: a population-based study. Metabolism. 2002;51:838–42.CrossRef
37.
go back to reference Lee MJ, Jung CH, Kang YM, Jang JE, Leem J, Park JY, et al. Serum ceruloplasmin level as a predictor for the progression of diabetic nephropathy in Korean men with type 2 diabetes mellitus. Diabetes Metab. 2015;39:230–9.CrossRef Lee MJ, Jung CH, Kang YM, Jang JE, Leem J, Park JY, et al. Serum ceruloplasmin level as a predictor for the progression of diabetic nephropathy in Korean men with type 2 diabetes mellitus. Diabetes Metab. 2015;39:230–9.CrossRef
39.
go back to reference Schramm JC, Dinh T, Veves A. Microvascular changes in the diabetic foot. Int J Low Extrem Wounds. 2006;5:149–59.CrossRef Schramm JC, Dinh T, Veves A. Microvascular changes in the diabetic foot. Int J Low Extrem Wounds. 2006;5:149–59.CrossRef
Metadata
Title
Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study
Authors
B. Zantour
S. Bouchareb
Z. El Ati
F. Boubaker
W. Alaya
W. Kossomtini
M. H. Sfar
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Diabetic Foot
Published in
BMC Endocrine Disorders / Issue 1/2020
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-020-00608-2

Other articles of this Issue 1/2020

BMC Endocrine Disorders 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.